Publications

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada

Wendt, D. C., Marsan, S., Parker, D., Lizzy, K. E., Roper, J., Mushquash, C., Venner, K. L., Lam, A., Swansburg, J., Worth, N., Sorlagas, N., Quach, T., Manoukian, K., Bernett, P., & Radin, S. M. Journal of Substance Abuse Treatment, 2021-02-01, Volume 121, Article 108165 CONSULTER

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada Lire la suite »

Applicability of the four-factor personality vulnerability model for substance misuse in understanding gambling behaviour and gambling problems.

Otis, E., Yakovenko, I., Sherry, S., Smith, M., Goldstein, A.L., Ellery, M., Loverock, A., Wild, T.C., Weilgart-Whitehead, B., & Stewart, S. Personality and Individual Differences, Volume 169, 1 February 2021, 110400 CONSULTER

Applicability of the four-factor personality vulnerability model for substance misuse in understanding gambling behaviour and gambling problems. Lire la suite »

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting

Elena Argento, M Eugenia Socias, Kanna Hayashi, JinCheol Choi, Lindsay Mackay, Devon Christie, M-J Milloy, Kora DeBeck Int J Drug Policy. 2022 Feb;100:103518. doi: 10.1016/j.drugpo.2021.103518. Epub 2021 Nov 7. PMID: 34758431; PMCID: PMC8890776. CONSULTER

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting Lire la suite »

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial

Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip , Jean-François Cailhier, Didier Jutras-Aswad Neuropsychopharmacol. 46, 2101–2111 (2021). https://doi.org/10.1038/s41386-021-01098-z CONSULTER

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial Lire la suite »

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison

Curtis M., Berk J., Larney S., Rich J., & Stoové M. J Public Health Policy. 2022 Mar;43(1):149-154. doi: 10.1057/s41271-021-00327-5. Epub 2022 Jan 8. PMID: 34997211 CONSULTER

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison Lire la suite »